Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Non-controlling interests
Beginning balance (in shares) at Dec. 31, 2021   85,327,000        
Beginning balance at Dec. 31, 2021 $ 1,566,515 $ 853 $ 1,727,667 $ (193,706) $ 9,904 $ 21,797
Ending balance (in shares) at Mar. 31, 2022   86,720,000        
Ending balance at Mar. 31, 2022 1,613,994 $ 867 1,783,938 (181,282) (12,341) 22,812
Beginning balance (in shares) at Dec. 31, 2021   85,327,000        
Beginning balance at Dec. 31, 2021 1,566,515 $ 853 1,727,667 (193,706) 9,904 21,797
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 27,166     26,896   270
Unrealized gain (loss) on available-for-sale securities (44,158)       (43,720) (438)
Unrealized gain (loss) on interest rate swaps 11,801       11,684 117
Issued shares of common stock (in shares)   1,781,000        
Issued shares of common stock 77,794 $ 18 77,776      
Equity-based compensation 15,933   1,938     13,995
Conversion of Convertible Notes (in shares)   283,000        
Conversion of Convertible Notes 7,674 $ 3 7,671      
Issuance (repurchase) of vested equity-based compensation shares (in shares)   99,000        
Issuance (repurchase) of vested equity-based compensation shares (3,162) $ 1 (3,163)      
Dividends and distributions (68,048)     (65,780)   (2,268)
Ending balance (in shares) at Jun. 30, 2022   87,490,000        
Ending balance at Jun. 30, 2022 1,591,515 $ 875 1,811,889 (232,590) (22,132) 33,473
Beginning balance (in shares) at Mar. 31, 2022   86,720,000        
Beginning balance at Mar. 31, 2022 1,613,994 $ 867 1,783,938 (181,282) (12,341) 22,812
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (18,538)     (18,449)   (89)
Unrealized gain (loss) on available-for-sale securities (21,448)       (21,188) (260)
Unrealized gain (loss) on interest rate swaps 11,512       11,397 115
Issued shares of common stock (in shares)   731,000        
Issued shares of common stock 27,934 $ 8 27,926      
Equity-based compensation 12,392   976     11,416
Issuance (repurchase) of vested equity-based compensation shares (in shares)   39,000        
Issuance (repurchase) of vested equity-based compensation shares (951)   (951)      
Dividends and distributions (33,380)     (32,859)   (521)
Ending balance (in shares) at Jun. 30, 2022   87,490,000        
Ending balance at Jun. 30, 2022 $ 1,591,515 $ 875 1,811,889 (232,590) (22,132) 33,473
Beginning balance (in shares) at Dec. 31, 2022 90,837,008 90,837,000        
Beginning balance at Dec. 31, 2022 $ 1,664,746 $ 908 1,924,200 (285,474) (10,397) 35,509
Ending balance (in shares) at Mar. 31, 2023   91,658,000        
Ending balance at Mar. 31, 2023 $ 1,658,815 $ 917 1,946,904 (297,708) (32,820) 41,522
Beginning balance (in shares) at Dec. 31, 2022 90,837,008 90,837,000        
Beginning balance at Dec. 31, 2022 $ 1,664,746 $ 908 1,924,200 (285,474) (10,397) 35,509
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 38,120     37,628   492
Unrealized gain (loss) on available-for-sale securities 3,568       3,521 47
Unrealized gain (loss) on interest rate swaps (1,116)       (1,127) 11
Issued shares of common stock (in shares)   15,867,000        
Issued shares of common stock 358,973 $ 159 358,814      
Equity-based compensation 11,478   1,675     9,803
Conversion of Convertible Notes 2   2      
Issuance (repurchase) of vested equity-based compensation shares (in shares)   66,000        
Issuance (repurchase) of vested equity-based compensation shares (1,435) $ 1 (1,436)      
Dividends and distributions $ (80,431)     (78,567)   (1,864)
Ending balance (in shares) at Jun. 30, 2023 106,769,719 106,770,000        
Ending balance at Jun. 30, 2023 $ 1,993,905 $ 1,068 2,283,255 (326,413) (8,003) 43,998
Beginning balance (in shares) at Mar. 31, 2023   91,658,000        
Beginning balance at Mar. 31, 2023 1,658,815 $ 917 1,946,904 (297,708) (32,820) 41,522
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 13,522     13,522    
Unrealized gain (loss) on available-for-sale securities (5,308)       (5,238) (70)
Unrealized gain (loss) on interest rate swaps 30,651       30,055 596
Issued shares of common stock (in shares)   15,104,000        
Issued shares of common stock 335,717 $ 151 335,566      
Equity-based compensation 3,580   901     2,679
Conversion of Convertible Notes 2   2      
Issuance (repurchase) of vested equity-based compensation shares (in shares)   8,000        
Issuance (repurchase) of vested equity-based compensation shares (118)   (118)      
Dividends and distributions $ (42,956)     (42,227)   (729)
Ending balance (in shares) at Jun. 30, 2023 106,769,719 106,770,000        
Ending balance at Jun. 30, 2023 $ 1,993,905 $ 1,068 $ 2,283,255 $ (326,413) $ (8,003) $ 43,998